Primenenie v tkanevoy inzhenerii krupnykh sosudov transplantatov na osnove autogennykh mononuklearnykh kletok kostnogo mozga

References

[1] Every N., Maynard С, Cochran R. et al. Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery. Circulation 1ЭЭБ; 94 (suppl. II): II-81-II-6.

[2] Kirklin J., Barratt-Boyes B. Ventricular septal defect and pulmonary stenosis or atresia. New York: Churchill Livingstone, 1993.

[3] Langer R., Vacanti J.P. Tissue Engineering. Science 1993; 2B0: 92D-6.

[4] 4. L'Heureux N., Paquet S., Labbe R. et al. A completely biological tissue-engineered human blood vessel. FASEB J. 1998; 12: 47-5Б.

[5] Hoerstrup S.P., Zund G., Sodian R. et al. Tissue engineering of small caliber vascular grafts. Eur. J. Cardiothorac. Surg. 20D1; 2D: 164-9.

[6] Б. Sumpio B.E. Hemodynamic forces and vascular cell biology. Austin, TX: RG Landes Publishers; 1993; p.1-134.

[7] Kanda K., Matsuda Т., Oka T. In vitro reconstruction of hybrid vascular tissue. Hierarchic and oriented cell layers. ASAIO J. 1993; 39: M561-5.

[8] Kakisis J.D., Liapis CD., Breuer C. et al. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J. Vase. Surg. 2005; 41: 349-54.

[9] Homann M. Haehnel J.C., Mendler N. et al. Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur. J. Cardiothorac. Surg. 2000; 17: 624-30.

[10] Bermudez C.A., Dearani J.A., Puga F.J. et al. Late results of the peel operation for replacement of failing extracardiac conduits. Ann. Thorac. Surg. 2004; 77: 881-8.

[11] Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986;231:397-400.

[12] Shin'oka Т., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 2001; 344: 532-3.

[13] 13. L'Heureux N., Germain L., Labbe R., Auger F.A. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J. Vase. Surg. 1993; 17: 499-509.

[14] Hirai J., Kanda K., Oka Т., Matsuda T. Highly oriented, tubular hybrid vascular tissue for a low pressure circulatory system. ASAIO J. 1994; 40: M383-8..

[15] Hirai J., Matsuda T. Venous reconstruction using hybrid vascular tissue composed of vascular cells and collagen: tissue regeneration process. Cell Transplant. 1996; 5: 93-105.

[16] ShinokaT., Shum-Tim D., Ma P.X. et al. Creation of viable pulmonary artery autografts through tissue engineering. J. Thorac. Cardiovasc. Surg. 1998; 115: 532-46

[17] Shum-Tim D., Stock U., Hrkach J. et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann. Thorac. Surg. 1999; 68: 2298-305.

[18] Niklason L.E., Gao J., Abbott W.M. et al. Functional arteries grown in vitro. Science 1999; 284: 489-93.

[19] Watanabe M., Shin'oka Т., Tohyama S. et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 2001;7:429-39.

[20] Hoerstrup S.P., Kadner A., Breymann С et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann. Thorac. Surg. 2002; 74: 46-52.

[21] Matsumura G., Miyagawa-Tomita S., Shin'oka T. et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circul. 2003; 108: 1729-34.

[22] Matsumura G., Ishihara Y., Miyagawa-Tomita S. et al. Evaluation of tissue-engineered vascular autografts. Tissue Eng. 2006; 12: 3075-83.

[23] Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109.

[24] Ziche M., Morbidelli L., Masini E. et al. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem. Biophys. Res. Commun. 1993; 192: 1198.

[25] Babaei S., Teichert-Kuliszewska K., Zhang Q. et al. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am. J. Pathol. 2003; 162: 1927.

[26] Matsumura G., Hibino N., Ikada Y. et al. Successful application of tissue engineered vascular autografts: clinical experience. Biomat. 2003; 24: 2303-8.

[27] Shinoka Т., Breuer C.K., Tanel R.E. et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 1995; 60 [6 SupplJ: S513-6.

[28] Shinoka Т., Ma P.X., Shum-Tim D. et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circul. 1996; 94 [9 SupplJ: 11164-8.

[29] Shinoka Т., Shum-Tim D., Ma P.X. et al. Tissue-engineered heart valve leaflets: does cell origin affect outcome? Circul. 1997; 96[9 SupplJ: 11102-7.

[30] Довгань A.M., Зиньковский М.Ф., Лазоришинец В.В. и др. Результаты операции Фонтена при аномалиях сердца с функционально единственным желудочком. Укранський Медичний Часопис 2000; 16: 76-80.

[31] Shinoka Т., Breuer С. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J. Biol. Med. 2008; 81: 161-6.

[32] McKay R. Stem cells-hype and hope. Nature 2000; 406: 361-4.

[33] Takahashi Т., Kalka C, Masuda H. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999; 5: 434-8.

[34] Shintani S., Murohara Т., Ikeda H. et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circul. 2001; 103: 2776-9.

[35] 35.Asahara Т., Masuda H., Takahashi T. et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999; 85: 221-8.

RIGHTS & PERMISSIONS

Eco-Vector